Synexus Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Synexus Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013193
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Synexus Ltd (Synexus), a subsidiary of Synexus Clinical Research Limited, is a site management organisation that offers patient recruitment and trial management services. The company services include feasibility assessment, project management, patient engagement, patient-centric clinical trials, patient retention and others. Its therapeutic expertise spans across areas including CNS, allergy symptoms, asthma, copd, smoking cessation, sinusitis, obesity, endocrine disorders, cardiovascular, gout, osteoarthritis, osteopenia, osteoporosis, rheumatoid arthritis, dermatology, type I diabetes, diabetic foot ulcers and screenable medical conditions. Synexus undertakes clinical trials from phase II to IV. It has presence in Poland, Hungary, Ukraine, Germany, Romania, Bulgaria, South Africa and the US. Synexus is headquartered in Chorley, Lancashire, the UK.

Synexus Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Synexus Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Synexus Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Synexus Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Synexus Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Synexus Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Synexus Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Synexus Acquires Clinical Trial Site 10
Private Equity 11
LDC Acquires Synexus in Management Buy-Out Transaction for USD127.7 Million 11
Acquisition 12
LDC Divests Synexus Clinical Research for USD258 Million 12
Synexus Acquires Research Across America 13
Synexus Acquires Centrum Medyczne Osteomed, Clinical Research Company 14
Adcock Ingram Acquires Remaining 49% Stake In AddClin Research From Synexus 15
Synexus Ltd – Key Competitors 16
Synexus Ltd – Key Employees 17
Synexus Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Synexus Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Synexus Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Synexus Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Synexus Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Synexus Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Synexus Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Synexus Acquires Clinical Trial Site 10
LDC Acquires Synexus in Management Buy-Out Transaction for USD127.7 Million 11
LDC Divests Synexus Clinical Research for USD258 Million 12
Synexus Acquires Research Across America 13
Synexus Acquires Centrum Medyczne Osteomed, Clinical Research Company 14
Adcock Ingram Acquires Remaining 49% Stake In AddClin Research From Synexus 15
Synexus Ltd, Key Competitors 16
Synexus Ltd, Key Employees 17
Synexus Ltd, Other Locations 18
Synexus Ltd, Subsidiaries 19

★海外企業調査レポート[Synexus Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Commonwealth Bank of Australia:企業の戦略・SWOT・財務情報
    Commonwealth Bank of Australia - Strategy, SWOT and Corporate Finance Report Summary Commonwealth Bank of Australia - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Tetra Technologies, Inc.:企業の戦略・SWOT・財務情報
    Tetra Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tetra Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Kirin Holdings Co Ltd:企業の戦略・SWOT・財務情報
    Kirin Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Kirin Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • De La Rue Plc (DLAR):企業の財務・戦略的SWOT分析
    De La Rue Plc (DLAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Grupo Carso SA de CV:企業の戦略・SWOT・財務分析
    Grupo Carso SA de CV - Strategy, SWOT and Corporate Finance Report Summary Grupo Carso SA de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • UCB SA (UCB):医療機器:M&Aディール及び事業提携情報
    Summary UCB SA (UCB) is a biopharmaceutical company that discovers and develops novel medicines and solutions to help treat various diseases. It principally focuses on developing products for the treatment of central nervous system (CNS) and immunology related conditions. The company's key medicines …
  • BPH Energy Ltd (BPH):企業の財務・戦略的SWOT分析
    BPH Energy Ltd (BPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Gramercy Property Trust:企業のM&A・事業提携・投資動向
    Gramercy Property Trust - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Gramercy Property Trust Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Lamellar Biomedical Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Lamellar Biomedical Ltd (Lamellar Biomedical) is a biotechnology company that develops medical products using based on mimetics of extra-alveolar lamellar bodies. The company develops products using its proprietary Lamellasome technology that are mimetics of native extra-alveolar lamellar th …
  • Weyerhaeuser Co (WY):企業の財務・戦略的SWOT分析
    Weyerhaeuser Co (WY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Kwang Dong Pharmaceutical Co Ltd (009290):製薬・医療:M&Aディール及び事業提携情報
    Summary Kwang Dong Pharmaceutical Co Ltd (Kwang Dong) is a drug manufacturer that develops, manufactures and supplies pharmaceuticals, health drinks and supplements. The company’s pharmaceutical products comprise OTC drugs, ETC drugs, general supplements, OTC drinks, consumer drinks, functional drin …
  • Terumo BCT Inc:企業の戦略的SWOT分析
    Terumo BCT Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • TEGNA Inc (TGNA):企業の財務・戦略的SWOT分析
    TEGNA Inc (TGNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Seagate Technology Public Limited Company:企業の戦略・SWOT・財務分析
    Seagate Technology Public Limited Company - Strategy, SWOT and Corporate Finance Report Summary Seagate Technology Public Limited Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Kyowa Exeo Corporation:企業の戦略・SWOT・財務情報
    Kyowa Exeo Corporation - Strategy, SWOT and Corporate Finance Report Summary Kyowa Exeo Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Merus Labs International Inc (MSL):企業の財務・戦略的SWOT分析
    Summary Merus Labs International Inc (Merus Labs International), formerly Merus Labs Inc, a subsidiary of Norgine BV, is a pharmaceutical company that provides medicinal products. The company offers products in the therapeutic areas of cardiovascular, oncology support, women's health, urology, and i …
  • Dalet S.A. (DLT):企業の財務・戦略的SWOT分析
    Dalet S.A. (DLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • University of Colorado Technology Transfer Office-医療機器分野:企業M&A・提携分析
    Summary University of Colorado Technology Transfer Office (CU TTO), a subsidiary of University of Colorado (CU) is a technology transfer service provider that provides development and commercialization processes. The university provides services such as intellectual property management, commercializ …
  • Permian Basin Royalty Trust Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Permian Basin Royalty Trust Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Permian Basin Royalty Trust (Permian Basin Royalty) is an oil and gas company that owns overriding royalty rights in mineral properties in the US. The company provides oil and gas product …
  • JGC Corporation (1963):電力:M&Aディール及び事業提携情報
    Summary JGC Corporation (JGC) is an engineering contracting company. It offers engineering, procurement and construction services for various engineering contracts and projects in the areas of oil and gas development, petroleum refining, natural gas processing, petrochemicals, clean energy and power …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆